{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:40:02Z","timestamp":1758746402711,"version":"3.44.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["advancesinpediatrics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Pediatrics"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1016\/j.yapd.2007.03.007","type":"journal-article","created":{"date-parts":[[2007,8,18]],"date-time":"2007-08-18T07:16:34Z","timestamp":1187421394000},"page":"85-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in the Diagnosis and Treatment of Osteoporosis"],"prefix":"10.1016","volume":"54","author":[{"given":"Jill","family":"Simmons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Zeitler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Steelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yapd.2007.03.007_bib1","unstructured":"National Osteoporosis Foundation. Impact and overview 2006."},{"key":"10.1016\/j.yapd.2007.03.007_bib2","unstructured":"United States Department of Health & HumanServices. Bone health and osteoporosis: a report of the Surgeon General, 2006 [article online]. Available at: http:\/\/www.surgeongeneral.gov\/library\/bonehealth. Accessed 11 April, 2006."},{"issue":"Suppl 3","key":"10.1016\/j.yapd.2007.03.007_bib3","first-page":"71","article-title":"Normal acquisition and loss of bone mass","volume":"60","author":"Abrams","year":"2003","journal-title":"Horm Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jpeds.2005.02.002","article-title":"Quantitative bone analysis in children: current methods and recommendations","volume":"146","author":"Specker","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.yapd.2007.03.007_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1359\/JBMR.041005","article-title":"Males have larger skeletal size and bone mass than females, despite comparable body size","volume":"20","author":"Nieves","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib6","first-page":"4702","article-title":"Bone mineral acquisition in healthy Asian, Hispanic, Black, and Caucasian youth: a longitudinal study","volume":"84","author":"Bachrach","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1056\/NEJM198903023200903","article-title":"Reduced bone mass in daughters of women with osteoporosis","volume":"320","author":"Seeman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ymgme.2006.04.009","article-title":"Genetics of osteoporosis","volume":"88","author":"Huang","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib9","unstructured":"Online Mendelian Inheritance in Man, OMIM 259770, 2001 [article online]. Available at: www.ncbi.nlm.nih.gov\/entrez\/dispomim.cgi?id=259770. Accessed 7\u00a0December, 2006."},{"key":"10.1016\/j.yapd.2007.03.007_bib10","unstructured":"Online Mendelian Inheritance in Man, OMIM 601884, 2006 [article online]. Available at: www.ncbi.nlm.nih.gov\/entrez\/dispomim.cgi?id=601884. Accessed 7\u00a0December, 2006."},{"key":"10.1016\/j.yapd.2007.03.007_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/ard.57.6.346","article-title":"Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women","volume":"57","author":"Masud","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.yapd.2007.03.007_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/67.1.18","article-title":"Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis","volume":"67","author":"Nieves","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.yapd.2007.03.007_bib13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7326\/0003-4819-125-12-199612150-00004","article-title":"Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial","volume":"125","author":"Buckley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1359\/jbmr.2003.18.1.156","article-title":"Regional specificity of exercise and calcium during skeletal growth in girls: a randomized controlled trial","volume":"18","author":"Iuliano-Burns","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1359\/jbmr.060302","article-title":"A positive dose\u2013response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention","volume":"21","author":"Viljakainen","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bmj.38950.561400.55","article-title":"Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials","volume":"333","author":"Winzenberg","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.yapd.2007.03.007_bib17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archpedi.154.6.610","article-title":"Teenaged girls, carbonated beverage consumption, and bone fractures","volume":"154","author":"Wyshak","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"year":"1997","series-title":"Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride","author":"Institute of Medicine","key":"10.1016\/j.yapd.2007.03.007_bib18"},{"key":"10.1016\/j.yapd.2007.03.007_bib19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1542\/peds.104.5.1152","article-title":"American Academy of Pediatrics. Committee on Nutrition. Calcium requirements of infants, children, and adolescents","volume":"104","author":"Baker","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2007.03.007_bib20","first-page":"10","article-title":"Vitamin D deficiency in pregnant and breast-feeding women and their infants","volume":"17","author":"Daaboul","year":"1997","journal-title":"J Perinatol"},{"key":"10.1016\/j.yapd.2007.03.007_bib21","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1210\/jc.2002-021935","article-title":"Nutritional rickets with normal circulating 25-hydroxyvitamin D: a call for re-examining the role of dietary calcium intake in North American infants","volume":"88","author":"Delucia","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/07315724.1998.10718814","article-title":"Nutritional rickets in suburbia","volume":"17","author":"Pugliese","year":"1998","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.yapd.2007.03.007_bib23","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1542\/peds.107.4.e53","article-title":"Hypovitaminosis D in healthy schoolchildren","volume":"107","author":"El-Hajj","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2007.03.007_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00223-004-0096-y","article-title":"Vitamin D: a necessity for children and adolescents in Greece","volume":"77","author":"Lapatsanis","year":"2005","journal-title":"Calcif Tissue Int"},{"year":"1997","series-title":"Institute of Medicine, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for calcium phosphorus, magnesium, vitamin D and fluoride","key":"10.1016\/j.yapd.2007.03.007_bib25"},{"key":"10.1016\/j.yapd.2007.03.007_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002239900512","article-title":"The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study","volume":"63","author":"Hall","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1359\/jbmr.2000.15.3.515","article-title":"Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis","volume":"15","author":"Shiraki","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1359\/jbmr.2001.16.1.148","article-title":"Jumping improves hip and lumbar spine bone mass in prepubescent children: a randomized controlled trial","volume":"16","author":"Fuchs","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib29","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1542\/peds.112.6.e447","article-title":"A school-based exercise intervention elicits substantial bone health benefits: a 2-year randomized controlled trial in girls","volume":"112","author":"MacKelvie","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2007.03.007_bib30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ajcn\/77.4.985","article-title":"Effect of a calcium and exercise intervention on\u00a0the bone mineral status of 16-18-y-old adolescent girls","volume":"77","author":"Stear","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.yapd.2007.03.007_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00223-006-0058-7","article-title":"Self-reported lifetime physical activity and areal bone mineral density in healthy postmenopausal women: the importance of teenage activity","volume":"79","author":"Rideout","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-004-1734-y","article-title":"Alcohol intake as a risk factor for fracture","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","article-title":"Smoking and fracture risk: a meta-analysis","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02390832","article-title":"A meta-analysis of the effects of cigarette smoking on bone mineral density","volume":"68","author":"Ward","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jc.2006-1294","article-title":"Smoking in young men is associated with lower bone mineral density and reduced cortical thickness","volume":"92","author":"Lorentzon","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/07853890510007386","article-title":"Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?","volume":"37","author":"Rauch","year":"2005","journal-title":"Ann Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajmg.c.30072","article-title":"Osteogenesis imperfecta, current and future medical treatment","volume":"139","author":"Rauch","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.yapd.2007.03.007_bib38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jmg.39.6.382","article-title":"Testing for osteogenesis imperfecta in cases of suspected nonaccidental injury","volume":"39","author":"Marlowe","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.yapd.2007.03.007_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","article-title":"Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect","volume":"17","author":"Glorieux","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib40","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","article-title":"Type V osteogenesis imperfecta: a new form of brittle bone disease","volume":"15","author":"Glorieux","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","article-title":"Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease","volume":"31","author":"Ward","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.yapd.2007.03.007_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"key":"10.1016\/j.yapd.2007.03.007_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2796.1996.420765000.x","article-title":"Relationships between vitamin D, parathyroid hormone, and bone mineral density in inflammatory bowel disease","volume":"239","author":"Silvennoinen","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S8756-3282(98)00178-1","article-title":"Osteoporosis in adult patients with celiac disease","volume":"24","author":"Kemppainen","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.yapd.2007.03.007_bib45","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198803313181305","article-title":"Local and systemic factors in the pathogenesis of osteoporosis","volume":"318","author":"Raisz","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1695-4033(01)77666-7","article-title":"The tumor necrosis factor system and leptin in coeliac disease","volume":"55","author":"Blanco","year":"2001","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.yapd.2007.03.007_bib47","first-page":"201","article-title":"Reduced bone mineral content in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.yapd.2007.03.007_bib48","first-page":"669","article-title":"Reduced bone mineral density in patients with adult-onset growth hormone deficiency","volume":"78","author":"Holmes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib49","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1515\/JPEM.2002.15.9.1537","article-title":"Low vertebral cancellous bone density in peri-pubertal girls with Turner's syndrome and boys with hypogonadism","volume":"15","author":"Nanao","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib50","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1210\/jc.2004-0046","article-title":"The skeletal phenotype of men with previous constitutional delay of puberty","volume":"89","author":"Yap","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib51","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/jbmr.5650081210","article-title":"Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue","volume":"8","author":"Lakatos","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib52","first-page":"78","article-title":"Serum interleukin-6 and bone metabolism in patients with thyroid function disorders","volume":"82","author":"Lakatos","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib53","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1210\/jcem.83.6.4911","article-title":"Glucocorticoid effects on bone","volume":"83","author":"Reid","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib54","first-page":"1905","article-title":"The effect of Cushing's disease on bone mineral density, body composition, growth, and puberty: a report of an identical adolescent twin pair","volume":"81","author":"Leong","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib55","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yapd.2007.03.007_bib56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ndt\/16.3.479","article-title":"Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid-induced osteoporosis","volume":"16","author":"Sasaki","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.yapd.2007.03.007_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI113885","article-title":"Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures","volume":"83","author":"Canalis","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yapd.2007.03.007_bib58","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1210\/endo-125-3-1484","article-title":"Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture","volume":"125","author":"Linkhart","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.yapd.2007.03.007_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yapd.2007.03.007_bib60","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcb.10490","article-title":"Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone","volume":"89","author":"Locklin","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.yapd.2007.03.007_bib61","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.yapd.2007.03.007_bib62","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1359\/JBMR.050602","article-title":"Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D","volume":"20","author":"Horwitz","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib63","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/qjmed\/89.12.921","article-title":"Primary hyperparathyroidism in a paediatric hospital","volume":"89","author":"Lawson","year":"1996","journal-title":"QJM"},{"issue":"Suppl 2","key":"10.1016\/j.yapd.2007.03.007_bib64","first-page":"N44","article-title":"Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children's Center experience 1984-2001","volume":"17","author":"Hsu","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib65","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1542\/peds.2004-0804","article-title":"Primary hyperparathyroidism in pediatric patients","volume":"115","author":"Kollars","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2007.03.007_bib66","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archpedi.158.5.491","article-title":"Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors","volume":"158","author":"Krishnamoorthy","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.mph.0000162526.77400.78","article-title":"Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers","volume":"27","author":"Kelly","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.yapd.2007.03.007_bib68","first-page":"101","article-title":"Bone mineral density in survivors of childhood acute lymphoblastic leukemia","volume":"48","author":"Athanassiadou","year":"2006","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.yapd.2007.03.007_bib69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1067\/mpd.2002.125728","article-title":"Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia","volume":"141","author":"van der Sluis","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.yapd.2007.03.007_bib70","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/JCD:5:2:167","article-title":"Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood","volume":"5","author":"Lequin","year":"2002","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.yapd.2007.03.007_bib71","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1067\/mpd.2001.113102","article-title":"Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998","volume":"138","author":"Kadan-Lottick","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.yapd.2007.03.007_bib72","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1203\/01.pdr.0000219129.12960.c2","article-title":"Bone mineral density and bone metabolism in children treated for bone sarcomas","volume":"59","author":"Ruza","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib73","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1542\/peds.86.3.440","article-title":"Decreased bone density in adolescent girls with anorexia nervosa","volume":"86","author":"Bachrach","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2007.03.007_bib74","first-page":"2049","article-title":"Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea","volume":"84","author":"Grinspoon","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib75","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1210\/jc.2004-0723","article-title":"Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism","volume":"89","author":"Misra","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib76","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM198412203112503","article-title":"Osteoporosis in women with anorexia nervosa","volume":"311","author":"Rigotti","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib77","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jbmr.5650080511","article-title":"Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission","volume":"8","author":"Herzog","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib78","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1469-8749.2003.tb00853.x","article-title":"Prevalence of reduced bone mass in children and adults with spastic quadriplegia","volume":"45","author":"King","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yapd.2007.03.007_bib79","unstructured":"World Health Organization (WHO): assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of the WHO study group. Geneva (IL); 1994. WHO Technical Report Series 843. WHO."},{"key":"10.1016\/j.yapd.2007.03.007_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/JCD:7:1:17","article-title":"The Writing Group for the ISCD Position Conference. Diagnosis of osteoporosis in men, premenopausal women, and children","volume":"7","year":"2004","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.yapd.2007.03.007_bib81","series-title":"Pediatric bone: biology and diseases","first-page":"303","article-title":"Noninvasive techniques for bone mass measurement","author":"Mora","year":"2003"},{"issue":"Suppl 2","key":"10.1016\/j.yapd.2007.03.007_bib82","first-page":"11","article-title":"Measuring bone mass in children: can we really do it?","volume":"65","author":"Bachrach","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib83","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bone.2003.12.003","article-title":"Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography","volume":"34","author":"Leonard","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.yapd.2007.03.007_bib84","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00198-003-1551-8","article-title":"Can geometry-based parameters from pQCT and material parameters from quantitative ultrasound (QUS) improve the prediction of radial bone strength over that by bone mass (DXA)?","volume":"15","author":"Hudelmaier","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib85","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01623454","article-title":"The role of ultrasound in the assessment of osteoporosis: a review","volume":"7","author":"Njeh","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1359\/jbmr.1998.13.1.143","article-title":"Bone mineral density in girls with forearm fractures","volume":"13","author":"Goulding","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib87","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1359\/jbmr.2000.15.10.2011","article-title":"More broken bones: a 4-year double cohort study of\u00a0young girls with and without distal forearm fractures","volume":"15","author":"Goulding","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib88","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.2001.16.7.1337","article-title":"Increased body weight and decreased radial cross-sectional dimensions in girls with forearm fractures","volume":"16","author":"Skaggs","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib89","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2106\/00004623-199511000-00005","article-title":"Bone mineral density in children and adolescents who have spastic cerebral palsy","volume":"77","author":"Henderson","year":"1995","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.yapd.2007.03.007_bib90","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","article-title":"Bone mineral density and bone metabolism in Duchenne muscular dystrophy","volume":"14","author":"Bianchi","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib91","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib92","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s007740170002","article-title":"Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)","volume":"19","author":"Nishizawa","year":"2001","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib93","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1359\/jbmr.1997.12.7.1083","article-title":"Relationship of bone turnover to bone density and fractures","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib94","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0889-8529(05)70007-4","article-title":"Biochemical markers of bone turnover. Applications for osteoporosis","volume":"27","author":"Garnero","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.yapd.2007.03.007_bib95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13685530600708631","article-title":"The predictive role of bone turnover markers for BMD in middle-aged men","volume":"9","author":"Donescu","year":"2006","journal-title":"Aging Male"},{"key":"10.1016\/j.yapd.2007.03.007_bib96","first-page":"226","article-title":"Bone health in children and adolescents: a symposium at the annual meeting of the Pediatric Academic Societies\/Lawson Wilkins Pediatric Endocrine Society, May 2003","volume":"34","author":"Gordon","year":"2004","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.yapd.2007.03.007_bib97","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib98","first-page":"1846","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age","volume":"85","author":"Plotkin","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib99","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J","article-title":"Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study","volume":"43","author":"Bianchi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.yapd.2007.03.007_bib100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1067\/mpd.2002.128207","article-title":"Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial","volume":"141","author":"Henderson","year":"2002","journal-title":"J Pediatr"},{"issue":"Suppl 3","key":"10.1016\/j.yapd.2007.03.007_bib101","first-page":"929","article-title":"Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome","volume":"15","author":"Matarazzo","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib102","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","article-title":"Beneficial effect of long-term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"86","author":"Astrom","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yapd.2007.03.007_bib103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/JPEM.2002.15.2.163","article-title":"Pamidronate treatment of osteogenesis imperfecta\u2014lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation, and treatment response","volume":"15","author":"Zacharin","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib104","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1359\/jbmr.2003.18.4.610","article-title":"Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy","volume":"18","author":"Rauch","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib105","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1542\/peds.111.5.e601","article-title":"Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta","volume":"111","author":"Montpetit","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2007.03.007_bib106","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpeds.2005.10.041","article-title":"Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta","volume":"148","author":"Land","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.yapd.2007.03.007_bib107","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","article-title":"Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV","volume":"111","author":"Zeitlin","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2007.03.007_bib108","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1067\/mpd.2003.137","article-title":"Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions","volume":"142","author":"Steelman","year":"2003","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.yapd.2007.03.007_bib109","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jpeds.2004.06.066","article-title":"Short-term safety assessment in the use of intravenous zoledronic acid in children","volume":"145","author":"Hogler","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.yapd.2007.03.007_bib110","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00256-004-0804-8","article-title":"Bisphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases","volume":"33","author":"Fernandes","year":"2004","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.yapd.2007.03.007_bib111","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1359\/JBMR.051006","article-title":"Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta","volume":"21","author":"Dimeglio","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib112","first-page":"77","article-title":"Modern approach to children with osteogenesis imperfecta","volume":"12","author":"Zeitlin","year":"2003","journal-title":"J Pediatr Orthop B"},{"key":"10.1016\/j.yapd.2007.03.007_bib113","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0003-9993(98)90426-9","article-title":"Osteogenesis imperfecta in childhood: treatment strategies","volume":"79","author":"Engelbert","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.yapd.2007.03.007_bib114","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bone.2003.11.019","article-title":"Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy","volume":"34","author":"Arikoski","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.yapd.2007.03.007_bib115","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","article-title":"Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome","volume":"20","author":"Munns","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib116","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib117","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","article-title":"The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta","volume":"110","author":"Rauch","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yapd.2007.03.007_bib118","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00003495-200363040-00009","article-title":"Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.yapd.2007.03.007_bib119","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1440-1754.2003.00083.x","article-title":"Use of bisphosphonate therapy for osteoporosis in childhood and adolescence","volume":"39","author":"Batch","year":"2003","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.yapd.2007.03.007_bib120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2005-2036","article-title":"Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy","volume":"91","author":"Rauch","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.yapd.2007.03.007_bib121","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-006-0019-1","article-title":"The pathogenesis, epidemiology, and management of glucocorticoid-induced osteoporosis","volume":"75","author":"Van Staa","year":"2006","journal-title":"Calcif Tis Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib122","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1440-1754.2005.00720.x","article-title":"Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents","volume":"41","author":"Brown","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.yapd.2007.03.007_bib123","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S0012162206001526","article-title":"Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study","volume":"48","author":"Plotkin","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yapd.2007.03.007_bib124","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.bpo.0000150810.35794.e8","article-title":"Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series","volume":"25","author":"Sholas","year":"2005","journal-title":"J Pediatr Orthop"},{"issue":"3","key":"10.1016\/j.yapd.2007.03.007_bib125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2165\/00002018-199614030-00003","article-title":"Adverse effects of bisphosphonates. A comparative study","volume":"14","author":"Adami","year":"1996","journal-title":"Drug Saf"},{"key":"10.1016\/j.yapd.2007.03.007_bib126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1592\/phco.24.2.195.33143","article-title":"Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents","volume":"24","author":"Robinson","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.yapd.2007.03.007_bib127","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate","volume":"19","author":"Munns","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.yapd.2007.03.007_bib128","first-page":"10","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines","volume":"80","author":"Pickett","year":"2006","journal-title":"J Dent Hyg"},{"key":"10.1016\/j.yapd.2007.03.007_bib129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteopetrosis","volume":"349","author":"Whyte","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3181\/00379727-219-44310","article-title":"Insulin-like growth factors and bone: the osteoporosis connection revisited","volume":"219","author":"Rosen","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib131","first-page":"470","article-title":"Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women","volume":"79","author":"Holloway","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib132","first-page":"3864","article-title":"Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib133","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/JPEM.2005.18.6.589","article-title":"Growth hormone improves bone mineral content in children with cystic fibrosis","volume":"18","author":"Hardin","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib134","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2005.02259.x","article-title":"A retrospective study of growth hormone use in adolescents with cystic fibrosis","volume":"62","author":"Hardin","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.yapd.2007.03.007_bib135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0889-8529(02)00056-7","article-title":"New anabolic therapies in osteoporosis","volume":"32","author":"Rubin","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.yapd.2007.03.007_bib136","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib137","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis","volume":"350","author":"Lindsay","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2007.03.007_bib138","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib139","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI3914","article-title":"Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial","volume":"102","author":"Lane","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yapd.2007.03.007_bib140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF02279212","article-title":"The incorporation and removal of large amounts of strontium by physiologic mechanisms in mineralized tissues","volume":"2","author":"Johnson","year":"1968","journal-title":"Calcif Tissue Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib141","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jcp.1041540324","article-title":"Strontium induces murine keratinocyte differentiation in vitro in the presence of serum and calcium","volume":"154","author":"Li","year":"1993","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.yapd.2007.03.007_bib142","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yapd.2007.03.007_bib143","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0140-6736(00)02408-9","article-title":"Oral statins and increased bone mineral density in postmenopausal women","volume":"355","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2007.03.007_bib144","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1001\/jama.283.24.3211","article-title":"HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients","volume":"283","author":"Wang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.yapd.2007.03.007_bib145","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1210\/jcem.86.9.8001","article-title":"Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia","volume":"86","author":"Chan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib146","first-page":"53","article-title":"Regulation of osteoclast differentiation by statins","volume":"3","author":"Grasser","year":"2003","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.yapd.2007.03.007_bib147","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jbmr.5650110502","article-title":"Slow-release sodium fluoride in osteoporosis","volume":"11","author":"Pak","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib148","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jbmr.5650090216","article-title":"Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis","volume":"9","author":"Riggs","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.yapd.2007.03.007_bib149","first-page":"3013","article-title":"Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study","volume":"84","author":"Alexandersen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2007.03.007_bib150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00223-001-1050-x","article-title":"Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates","volume":"69","author":"Ringe","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.yapd.2007.03.007_bib151","first-page":"421","article-title":"Age-specific fluoride exposure in drinking water and osteosarcoma (United States)","volume":"17","author":"Bassin","year":"2006","journal-title":"Cancer Causes Control"}],"container-title":["Advances in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310107000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310107000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:07:54Z","timestamp":1758744474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065310107000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":151,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"alternative-id":["S0065310107000084"],"URL":"https:\/\/doi.org\/10.1016\/j.yapd.2007.03.007","relation":{},"ISSN":["0065-3101"],"issn-type":[{"type":"print","value":"0065-3101"}],"subject":[],"published":{"date-parts":[[2007]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the Diagnosis and Treatment of Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Advances in Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yapd.2007.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}